Danaher Corporation (DHR)
NYSE: DHR · Real-Time Price · USD
211.45
-0.76 (-0.36%)
Nov 6, 2025, 2:14 PM EST - Market open

Danaher Operating Metrics

Period EndingSep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018
Recurring Revenue
20.04B19.80B19.52B19.50B17.04B17.44B18.09B18.68B
Recurring Revenue Growth
17.63%13.52%7.90%4.37%-11.11%-11.95%-11.16%-10.51%
Period EndingSep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Diagnostics
9.86B9.76B9.71B9.79B9.87B9.76B9.73B9.58B
Diagnostics Growth
-0.08%0.01%-0.20%2.19%0.41%-4.82%-8.06%-11.72%
Life Sciences
7.28B7.27B7.26B7.33B7.23B7.15B7.18B7.14B
Life Sciences Growth
0.75%1.68%1.21%2.63%0.98%-22.50%-37.03%-47.38%
Biotechnology
7.13B6.98B6.85B6.76B6.65B6.66B6.83B7.17B-----------
Biotechnology Growth
7.22%4.86%0.22%-5.76%-12.93%--------------
Environmental and Applied Solutions
--------4.95B4.91B4.88B4.83B4.81B4.75B4.68B4.65B
Environmental and Applied Solutions Growth
--------2.76%3.20%4.38%3.81%4.61%5.04%7.00%8.04%
Period EndingSep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Diagnostics
2.56B2.51B2.51B2.63B2.77B2.69B2.56B2.41B
Diagnostics Growth
-7.44%-6.69%-1.80%9.10%5.25%-5.61%-20.70%-29.98%
Biotechnology
1.83B1.87B1.74B1.63B1.53B1.56B1.64B1.91B-----------
Biotechnology Growth
19.50%19.87%6.29%-14.88%-29.87%--------------
Environmental
--------1.19B1.19B1.20B1.14B1.06B1.03B1.01B1.05B
Environmental Growth
--------12.34%15.60%19.20%7.69%-2.84%-4.62%-1.86%7.66%
Life Sciences
560.00M373.00M845.00M879.00M738.00M1.02B1.12B1.21B
Life Sciences Growth
-24.12%-63.29%-24.76%-27.30%-45.97%-51.57%-61.70%-67.58%
Other
-340.00M-337.00M-334.00M-326.00M-323.00M-358.00M-392.00M-413.00M
Period EndingSep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019
North America
10.45B10.25B10.25B10.30B10.11B10.71B11.20B11.59B--
North America Growth
3.39%-4.30%-8.55%-11.20%-20.23%-18.75%-17.84%-17.00%--
High Growth Markets
6.88B6.87B6.87B6.87B6.88B7.23B7.73B8.28B--
High Growth Markets Growth
-0.04%-5.03%-11.17%-17.03%-21.28%-19.12%-14.85%-9.26%--
Western Europe
5.86B5.66B5.48B5.46B5.31B5.58B5.96B6.35B--
Western Europe Growth
10.41%1.53%-8.17%-14.04%-21.16%-18.06%-12.16%-8.13%--
Other Developed Markets
1.25B1.23B1.23B1.25B1.27B1.30B1.33B1.38B--
Other Developed Markets Growth
-1.51%-5.03%-7.68%-9.21%-10.53%-8.99%-7.76%-5.92%--
Period EndingSep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019
Selling, General, and Administrative
8.23B8.30B7.81B7.76B7.77B7.86B8.18B8.52B
Selling, General, and Administrative Growth
5.93%5.66%-4.53%-8.94%-10.43%-9.49%-4.55%0.06%
Research and Development
1.60B1.61B1.60B1.58B1.55B1.58B1.61B1.67B
Research and Development Growth
3.42%1.52%-0.93%-5.21%-9.78%-7.97%-7.10%-4.24%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.